Pena Luis C. 4

What Happened
Luis C. Pena, President & CEO and a director of Evommune, sold 7,438 shares on June 22, 2026, for total proceeds of approximately $168,917. The reported weighted-average price was $22.71 per share; individual trades in the block ranged from $22.50 to $22.99.

Key Details

• Transaction date: 2026-06-22; Form 4 filed 2026-06-24 (timely filing).
• Type: Sale (open market/private sale) — 7,438 shares disposed.
• Price: Weighted average $22.71; range $22.50–$22.99.
• Total proceeds: ~$168,917.
• Footnotes: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted March 2, 2026. The filer can provide a breakdown of the number of shares sold at each price in the stated range upon request.
• Shares owned after the transaction: Not specified in the supplied filing details.

Context
This sale was executed under a pre-established 10b5-1 plan, which often indicates the trades were pre-planned rather than reactionary. Sales do not necessarily signal management sentiment about the company; purchases are typically more informative when assessing insider conviction.